Ra Medical Systems to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Rhea-AI Summary

Ra Medical Systems (NYSE American: RMED) will participate in the H.C. Wainwright Global Life Sciences Virtual Conference on March 9-10, 2021. The company will present its overview and engage in virtual meetings with investors. The webcast will be accessible starting March 9, 2021, at 7:00 a.m. Eastern Time until March 10, 2021, at 9:00 p.m. Eastern Time. Ra Medical's products include the DABRA and Pharos excimer laser systems, both FDA-approved for treating vascular and dermatological diseases, and are manufactured in a certified facility in Carlsbad, California.

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces that management will present a company overview and hold virtual meetings with investors at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021.

The Ra Medical Systems presentation can be accessed by registering for the H.C. Wainwright Global Life Sciences Virtual Conference here. The webcast will be available on the H.C. Wainwright Conference Portal beginning March 9, 2021 at 7:00 a.m. Eastern time through March 10, 2021 at 9:00 p.m. Eastern time. The Company’s corporate presentation can be accessed from the Investor Relations section of the Company website here.

About Ra Medical Systems

Ra Medical Systems commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases. In May 2017 the DABRA excimer laser system received FDA 510(k) clearance in the U.S. for crossing chronic total occlusions, or CTOs, in patients with symptomatic infrainguinal lower extremity vascular disease with an intended use for ablating a channel in occlusive peripheral vascular disease. The Pharos excimer laser system is FDA-cleared and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. DABRA and Pharos are both based on Ra Medical’s core excimer laser technology platform and deploy similar mechanisms of action. Ra Medical manufactures DABRA and Pharos excimer lasers and catheters in a 32,000-square-foot facility located in Carlsbad, Calif. The vertically integrated facility is ISO 13485 certified and is licensed by the State of California to manufacture sterile, single-use catheters in controlled environments.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005253/en/

FAQ

What is the focus of Ra Medical Systems?

Ra Medical Systems focuses on commercializing excimer laser systems for treating vascular and dermatological diseases.

When is the H.C. Wainwright Global Life Sciences Conference?

The conference will be held on March 9-10, 2021.

How can I access Ra Medical Systems' presentation?

You can access the presentation by registering for the conference, which is available starting March 9, 2021, at 7:00 a.m. Eastern Time.

What products does Ra Medical Systems manufacture?

Ra Medical manufactures the DABRA and Pharos excimer laser systems, both of which are FDA-cleared.

Where is Ra Medical Systems located?

Ra Medical Systems is located in Carlsbad, California.